Entrada Therapeutics, Inc. (TRDA)
NASDAQ·Healthcare·Biotechnology
$12.75
-1.09%
Mkt Cap $483.53M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$18.00
Range $13.00 – $21.00
Implied Upside
+41.2%
Consensus $18.00 vs current $12.75
NASDAQ·Healthcare·Biotechnology
$12.75
-1.09%
Mkt Cap $483.53M
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$18.00
Range $13.00 – $21.00
+41.2%
Consensus $18.00 vs current $12.75